SkinHealth Systems Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except for share amounts)

	March 31, 2026	December 31, 2025
ASSETS
Current assets:
Cash, cash equivalents, and restricted cash	$204,358	$232,673
Accounts receivable, net of allowances for estimated credit losses of $4,988 and $6,022 at March 31, 2026 and December 31, 2025, respectively	18,615	21,741
Inventories	47,693	48,012
Income tax receivable	1,638	1,696
Prepaid expenses and other current assets	5,391	5,395
Total current assets	277,695	309,517
Property and equipment, net	2,336	2,538
Right-of-use assets, net	20,293	11,570
Intangible assets, net	32,798	35,763
Goodwill	126,246	126,621
Deferred income tax assets, net	2,413	1,925
Other assets	11,452	11,869
TOTAL ASSETS	$473,233	$499,803
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of convertible senior notes, net	$102,944	$123,959
Accounts payable	15,885	15,631
Accrued payroll-related expenses	13,031	24,947
Lease liabilities, current	4,158	5,128
Income tax payable	462	1,226
Other accrued expenses	18,722	15,384
Total current liabilities	155,202	186,275
Lease liabilities, non-current	18,751	9,238
Deferred income tax liabilities, net	393	393
Convertible senior notes, net	241,276	240,431
Other long-term liabilities	2,371	2,410
Total liabilities	417,993	438,747
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 129,144,801 and 127,520,823 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	13	13
Additional paid-in capital	581,053	579,961
Accumulated other comprehensive loss	(1,712)	(1,434)
Accumulated deficit	(524,114)	(517,484)
Total stockholders’ equity	55,240	61,056
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$473,233	$499,803

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.